Perimeter Schedules First Quarter 2026 Financial Results Conference Call for May 28th

Rhea-AI Summary

Perimeter Medical Imaging AI (OTCQX:PYNKF) will release its first quarter 2026 financial and operating results after market close on Thursday, May 28, 2026. Management will host a webcast and conference call at 5:00 p.m. Eastern Time to discuss results and provide a corporate update.

The call will be accessible via dial-in numbers for North America and international participants and will also be broadcast live and archived on the company’s website for later listening.

AI-generated analysis. Not financial advice.

TORONTO and DALLAS, May 21, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its first quarter 2026 financial and operating results after market close on Thursday, May 28, 2026. Following the announcement, Perimeter management will host a webcast and conference call to discuss the results and provide a corporate update.

First Quarter Results Conference Call Details:

Date:	Thursday, May 28, 2026
Time:	5:00 pm Eastern Time
Dial-In Numbers:	1-800-717-1738 (Canada and the United States) or 1-646-307-1865 (International)

The call will also be broadcast live and archived on the Company's website here.

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Claire™, recently approved by the U.S. Food and Drug Administration (FDA), is our next-generation AI-enabled device. The Company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month.

Indications for Use: The Claire OCT System is an adjunctive three-dimensional imaging tool which provides volumetric cross-sectional, real-time depth visualization, coupled with an artificial intelligence computer-aided detection algorithm which identifies and marks focal areas suspicious for breast cancer. It is used concurrently with physician interpretation of the images. The Claire OCT System is intended for use in conjunction with other standard methods for evaluation of the margins of excised lumpectomy tissue during surgical procedures in patients with a biopsy-confirmed diagnosis of breast cancer.

The Claire OCT System should not be used to replace standard tissue histopathology assessment and should not be used for diagnosis. The device is not intended for use in any of the following individuals: under the age of 18, male, have metastatic cancer (Stage IV), have lobular carcinoma as their primary diagnosis, have had previous ipsilateral breast surgery for benign or malignant disease within two years (including implants and breast augmentation), patients with multi-centric disease (histologically diagnosed cancer in two different quadrants of the breast), unless resected in a single specimen, patients with bilateral disease (diagnosed cancer in both breasts), patients who are currently lactating, patients who are currently pregnant, or concurrent use in surgeries with cryo-assisted localization. Refer to prescriber labeling for full safety information.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CONTACTS:

Stephen Kilmer
Investor Relations
Direct: 647-872-4849
Email: skilmer@perimetermed.com

Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Email: investors@perimetermed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/perimeter-schedules-first-quarter-2026-financial-results-conference-call-for-may-28th-302779422.html

SOURCE Perimeter Medical Imaging AI Inc.

FAQ

When will Perimeter Medical Imaging AI (PYNKF) report Q1 2026 results?

Perimeter Medical Imaging AI will report its Q1 2026 financial and operating results on Thursday, May 28, 2026 after market close. According to the company, this release will be followed by a webcast and conference call the same day.

What time is Perimeter Medical Imaging AI (PYNKF) Q1 2026 earnings conference call?

The Perimeter Medical Imaging AI Q1 2026 conference call is scheduled for 5:00 p.m. Eastern Time on May 28, 2026. According to the company, management will discuss the results and provide a corporate update during the webcast.

How can investors join the Perimeter Medical Imaging AI (PYNKF) Q1 2026 results call?

Investors can join the Perimeter Q1 2026 call by dialing 1-800-717-1738 in Canada and the United States or 1-646-307-1865 internationally. According to the company, the call will also stream live on its website.

Will the Perimeter Medical Imaging AI (PYNKF) Q1 2026 webcast be available for replay?

Yes, the Perimeter Q1 2026 results webcast will be archived on the company’s website after the live event. According to the company, investors can access the replay online for later listening.

What will Perimeter Medical Imaging AI (PYNKF) management cover on the May 28, 2026 call?

Perimeter management will discuss first quarter 2026 financial and operating results and provide a corporate update on the May 28 call. According to the company, this includes commentary following the after-market-close results release.

What are the dial-in numbers for Perimeter Medical Imaging AI (PYNKF) Q1 2026 conference call?

The dial-in numbers are 1-800-717-1738 for Canada and the United States and 1-646-307-1865 for international callers. According to Perimeter, these numbers connect participants to the May 28, 2026 results call.